Home ••• Newswires by Industry • Countries • U.S. States • World Media Directory

Pharmaceutical Industry News ••• Topics • Countries • U.S. States

Australia Pharmaceutical Industry News ••• Topics • Australia Media Directory

Australia Adverse Event News Monitoring

Get by Email • RSS

Published on 11:48 GMT

Ayahuasca’s Long-Term Psychological Effects Explained

Some acute post-ayahuasca “adverse effects” like visual distortions were associated with better reported mental health at a later date, while other adverse effects like feeling isolated or energetically attacked were associated with worse mental health …

Source: Innovations Report - Neutral
Published on 06:41 GMT

Metformin Beneficial for Osteoarthritis Knee Pain in Overweight, Obesity

THURSDAY, May 1, 2025 (HealthDay News) — For patients with overweight or obesity and symptomatic knee osteoarthritis, metformin is associated with a greater improvement in knee pain than placebo, according to a study published online April 24 in the …

Source: Physician's Weekly - Neutral
Published on 00:35 GMT

RAC doses first patient in solid tumour RC220 trial

First patient dosed at lead trial site, Southside Cancer Care. Phase 1 trial to determine safety, tolerability and pharmacokinetic data, plus maximum tolerated combined dose of RC220 with chemotherapeutic doxorubicin. Up to 33 patients to be recruited in …

Source: Townsville Bulletin - Center-right
Published on May 1, 2025

Race Oncology doses first patient in RC220 Phase 1 solid tumour trial

The first of up to 32 patients has been safely dosed in RAC’s Phase 1 clinical trial assessing RC220 in solid tumours. Pic: Getty Images. First patient dosed at lead trial site, Southside Cancer Care. Phase 1 trial to determine safety, tolerability and …

Source: Stockhead - Neutral
Published on May 1, 2025

AI In Medical Devices: Meeting The Regulatory Challenge Around The World, Part 1

By Marcelo Trevino, independent expert Artificial intelligence (AI) and machine learning (ML) are redefining healthcare, from enabling earlier diagnoses and personalized treatments to streamlining hospital operations and accelerating medical research. But …

Source: Med Device Online - Pending
Published on Apr 30, 2025

Improving Outcomes with Combination Therapies for PSMA Radioligand Treatment "Presentation" - Michael Hofman

Read the Full Video Transcript Michael Hofman: For the invitation today. This afternoon, I'm going to be talking on improving outcomes with combination therapies. It's actually-- this year will be our 10th year anniversary since we did our first …

Source: UroToday - Neutral
Published on Apr 30, 2025

Novel Targeted Therapy Shows Promise for Advanced Lung Cancer with HER2 Mutations

Nearly three quarters of non-small cell lung cancer (NSCLC) patients with HER2 mutations experienced tumor regression when treated with zongertinib, a novel targeted therapy, according to results from the main cohort of an early study presented at the …

Source: Cancer Health - Pending
Published on Apr 30, 2025

Phase 1 study of HP518, a PROTAC AR degrader in patients with mCRPC: results on safety, pharmacokinetics, and anti-tumor ...

HP518 is an oral PROteolysis TArgeting Chimera (PROTAC) protein degrader targeting the wild-type androgen receptor (WT-AR) and mutant AR ligand-binding domain (AR-LBD). A multicenter, first-in-human, open-label Phase 1 dose escalation study was conducted …

Source: UroToday - Neutral
Published on Apr 30, 2025

Appendix 4C – Q3 FY25 Quarterly Cash Flow Report

Highlights Reported positive topline data for ATH434-201 randomized, double-blind Phase 2 clinical trial in Multiple System Atrophy (MSA) led by robust clinical efficacy Phase 2 data featured in an oral presentation at the American Academy of Neurology …

Distribution channels: Technology ...
Published on Apr 30, 2025

Struggling mothers reveal the dark side of the 'miracle' ADHD drug that was supposed to save their lives from chaos

'The flood of comments has been overwhelming,' explains Jane McFadden, host of the popular ADHD Mums podcast. 'People are at their wits' end, saying their homes are in chaos, and their kids are struggling, along with themselves.' …

Source: Daily Mail - Right-wing
Published on Apr 30, 2025

The Morning Briefing: Trump Put About 100 Months' Worth of Work Into His First 100 Days

Top O' the Briefing Happy Wednesday, dear Kruiser Morning Briefing friends. Alphozzus was determined to make "Butter Sauce Cheetos" a hit whenever he hosted Uncomfortable Puzzles night. I would like to begin by thanking everyone who …

Source: PJ Media - Virginia - Right-wing
Published on Apr 30, 2025

Development and Psychometric Evaluation of an Instrument to Assess Physical Activity Participation Behavior Among ...

Introduction Chronic Obstructive Pulmonary Disease (COPD) is currently one of the top three leading causes of death globally. In China, the overall prevalence rate is 8.6%, with a higher rate of 13.7% in individuals aged 40 and above. The total number of …

Source: Dove Medical Press - Neutral
Published on Apr 29, 2025

Baby colic item recalled over lack of evidence on its safety

A popular product purporting to help babies suffering from colic has been recalled and removed from the Australian Register of Therapeutic Goods. In a recall notice issued last week, the Department of Health said BlissBaby, the makers of the product Lufti …

Source: 9News - Neutral
Published on Apr 29, 2025

Measles: we’re on the precipice of a disaster, experts say

Measles may become endemic again in the US within 20 years if vaccination rates don’t improve, according to new modelling. Only 2 doses of the measles, mumps and rubella (MMR) vaccine are required to achieve 99% effectiveness to prevent infection from the …

Source: Cosmos - Neutral
Published on Apr 28, 2025

One in ten patient safety incidents in hospitals due to poor communication – new study

Patients’ lives are being put at risk by poor communication from healthcare professionals in hospitals worldwide, according to new research my colleagues and I conducted. Our analysis included 46 studies, published between 2013 and 2024, involving over 67, …

Source: The Conversation - Neutral
Published on Apr 29, 2025

CSL Vifor and Travere Therapeutics announce standard EU approval for FILSPARI® in IgA Nephropathy

European Commission converts conditional approval of FILSPARI (sparsentan) into standard marketing authorization for the treatment of IgA Nephropathy (IgAN) Decision follows positive recommendation from Committee for Medicinal Products for Human Use (CHMP) …

Source: WFMZ - Pennsylvania - Neutral
Published on Apr 28, 2025

Mesoblast Appoints Corporate Finance Leader Lyn Cobley To Board

NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- Mesoblast (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has appointed Lyn Cobley to its Board of Directors. Ms. Cobley has been a …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
Published on Apr 28, 2025

Reversible male birth control injectable lasts 2 years, moves to phase 2 human trials

Contraline, a biotech company, has received regulatory approval to move onto Phase 2 of human clinical trials for a male contraceptive that conveniently blocks sperm for up to two years. Contraline reached a critical milestone in passing Phase I of …

Source: Interesting Engineering - New York - Neutral
Published on Apr 28, 2025

Alterity Therapeutics Presents ATH434-201 Phase 2 Clinical Trial Results at European MSA Symposium

MELBOURNE, Australia and SAN FRANCISCO, April 28, 2025 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative …

Distribution channels: Culture, Society & Lifestyle, Media, Advertising & PR ...

03 days 15:38:41

Featured Releases

Got News to Share? · Submit · See All

Published on May 2, 2025 - 12:00 GMT

ARS Pharmaceuticals Announces Co-Promotion Agreement with Partner and Global Allergy Leader ALK-Abelló A/S to Expand ...

Agreement builds on landmark licensing deal between ARS Pharma and ALK-Abelló A/S, which provided ARS Pharma with $145 million upfront and ALK with commercialization rights to neffy in Canada, United Kingdom, European Union and certain other countries …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
Published on May 2, 2025 - 10:52 GMT

Omega-3 Market Poised for Robust Growth with Expanding Applications Across Nutrition, Pharmaceuticals & Personal Care

Omega 3 Market Research Report By Source, By Form, By Application, By End Use and By Regional-Forecast to 2035 NEW YORK, NY, UNITED STATES, May 2, 2025 /⁨EINPresswire.com⁩/ -- The global Omega-3 Market is experiencing significant momentum, driven …

Distribution channels: Food & Beverage Industry ...

Published on May 2, 2025 - 06:30 GMT

Nxera Pharma Operational Highlights and Consolidated Results for the First Quarter 2025

Tokyo, Japan and Cambridge, UK, 2 May 2025 – Nxera Pharma (“the Company” or “Nxera”; TSE: 4565) provides an update on operational activities and reports its consolidated results for the first quarter ended 31 March 2025. The full report can be found here. …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on May 2, 2025 - 10:03 GMT

Rosuvastatin Calcium Market CAGR 5.11 % with Growth USD 940.6 Billion by 2033

Rosuvastatin Calcium market size in 2025 is estimated to be 631.33 million, with projections to grow to 940.6 million by 2033 at a CAGR of 5.11%. PUNE, MAHARASHTRA, INDIA, May 2, 2025 /⁨EINPresswire.com⁩/ -- "Rosuvastatin Calcium Market" …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on May 2, 2025 - 02:56 GMT

OBI Pharma reçoit l’approbation de la FDA à la suite de sa demande d’étude clinique de la Phase I/II pour OBI-902, un ...

TAIPEI, Taïwan, 02 mai 2025 (GLOBE NEWSWIRE) -- OBI Pharma, Inc. (« OBI »), un laboratoire d’oncologie au stade clinique (4174.TWO), annonce ce jour que l’Agence américaine des produits alimentaires et médicamenteux, la Food and Drug Administration, ou « …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 2, 2025 - 02:56 GMT

OBI Pharma gibt bekannt, dass die US-Arzneimittelbehörde FDA den IND-Antrag für eine Phase-1/2-Studie mit OBI-902, einem ...

TAIPEI, Taiwan, May 02, 2025 (GLOBE NEWSWIRE) -- OBI Pharma, Inc. („OBI“), ein Onkologieunternehmen in der klinischen Phase (4174.TWO), hat heute bekannt gegeben, dass die US-amerikanische Arzneimittelbehörde FDA (Food and Drug Administration) den Antrag …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 2, 2025 - 07:23 GMT

Hidradenitis Suppurativa Treatment Market Poised for Growth: Advancements in Therapeutics and Diagnostics | FMI

The expected to advance noticeably over the forecast period owing to ongoing research towards targeted biologic therapeutics and newer drug formulation. NEWARK, DE, UNITED STATES, May 2, 2025 /⁨EINPresswire.com⁩/ -- The hidradenitis suppurativa …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 2, 2025 - 08:45 GMT

Orion Corporation: Managers’ transactions – Veli-Matti Mattila

ORION CORPORATION MANAGERS’ TRANSACTIONS 2 MAY 2025 at 11.45 EEST Orion Corporation: Managers’ transactions – Veli-Matti Mattila Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...

Got news to share? Submit it now.

Load more pharmaceuticals news or search news using your own keywords. There are 808,833,656 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

Pharmaceutical Industry News by Country

Pharmaceutical Industry News by U.S. State

Pharmaceutical Industry News Topics

Online News Publications

World News Report

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Create Email Newsletter

Create RSS Feed

NewsPlugin for WordPress

Submit News

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

EIN Presswire

Events

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 04/18/2025

World Media Directory

Healthcare & Pharmaceuticals Industry Press Releases

Got News to Share? · Submit · See All

Published on May 2, 2025 - 12:17 GMT

ProHance Sparks Conversations on AI and Workforce Analytics at Shared Services & GCC Week India 2025

ProHance leads impactful dialogue on AI and workforce analytics at SSOW India 2025, showcasing insights to shape the future of shared services. BENGALURU, KARNATAKA, INDIA, May 2, 2025 /⁨EINPresswire.com⁩/ -- ProHance, a new-age workplace …

Distribution channels: Banking, Finance & Investment Industry, Building & Construction Industry ...
Published on May 2, 2025 - 11:30 GMT

MindInventory Achieves Google Cloud Partner Status in Build Engagement Model to Accelerate Enterprise Innovation

Enhanced collaboration enables development of AI-powered industry solutions across healthcare, retail, and financial services sectors. STRONGSVILLE, OH, UNITED STATES, May 2, 2025 /⁨EINPresswire.com⁩/ -- MindInventory, a leading digital solutions provider …

Distribution channels: Education, Healthcare & Pharmaceuticals Industry ...
Published on May 2, 2025 - 10:56 GMT

New Data Highlights Soaring Rates of Teen Mental Health Challenges in California and the USA

Teen mental health issues in California surge; data shows urgent need for awareness and accessible adolescent treatment programs across the state. LOS ANGELES, CA, UNITED STATES, May 2, 2025 /⁨EINPresswire.com⁩/ -- Recent data paints a concerning picture …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 2, 2025 - 10:03 GMT

Rosuvastatin Calcium Market CAGR 5.11 % with Growth USD 940.6 Billion by 2033

Rosuvastatin Calcium market size in 2025 is estimated to be 631.33 million, with projections to grow to 940.6 million by 2033 at a CAGR of 5.11%. PUNE, MAHARASHTRA, INDIA, May 2, 2025 /⁨EINPresswire.com⁩/ -- "Rosuvastatin Calcium Market" …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 2, 2025 - 08:05 GMT

Celebrating One Year of 5-Star Urgent Care Services in Clear Lake, Houston

HOUSTON, TX, UNITED STATES, May 2, 2025 /⁨EINPresswire.com⁩/ -- Priority Urgent Care and Walk-In Clinic - Clear Lake proudly celebrates its one-year anniversary of delivering exceptional, patient-centered urgent care services in Clear Lake, with a …

Distribution channels: Culture, Society & Lifestyle, Emergency Services ...
Published on May 2, 2025 - 07:47 GMT

PowerDMARC is an Official Sponsor of MSPGeekCon 2025 in Orlando

ORLANDO, FL, UNITED STATES, May 2, 2025 /⁨EINPresswire.com⁩/ -- PowerDMARC, a global leader in email authentication and DMARC management solutions, is excited to announce its sponsorship and participation at MSPGeekCon 2025, taking place May 4–6 at …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...
Published on May 2, 2025 - 07:39 GMT

Global Hyperpigmentation Treatment Market Set to Surpass USD 12.4 Million by 2035 reflecting a CAGR of 9.0% | FMI

Emerging trends in AI-based skin assessment, rising preference for plant-based solutions, and expansion of medical-grade skincare to drive 9.0% CAGR growth NEWARK, DE, UNITED STATES, May 2, 2025 /⁨EINPresswire.com⁩/ -- The global hyperpigmentation …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 2, 2025 - 07:23 GMT

Hidradenitis Suppurativa Treatment Market Poised for Growth: Advancements in Therapeutics and Diagnostics | FMI

The expected to advance noticeably over the forecast period owing to ongoing research towards targeted biologic therapeutics and newer drug formulation. NEWARK, DE, UNITED STATES, May 2, 2025 /⁨EINPresswire.com⁩/ -- The hidradenitis suppurativa …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 2, 2025 - 05:14 GMT

Drowning is the leading cause of death children ages 1-4

Drowning is a serious issue, how to become safer in, on, or near the water. NEW YORK, NY, UNITED STATES, May 2, 2025 /⁨EINPresswire.com⁩/ -- Drowning is the leading cause of death for children ages 1-4 May is National Water Safety Awareness …

Distribution channels: Culture, Society & Lifestyle, Education ...
Published on May 2, 2025 - 05:13 GMT

Qualiphy Simplifies Good Faith Exams for Medical Spas and Clinics

BEVERLY HILLS, CA, UNITED STATES, May 2, 2025 /⁨EINPresswire.com⁩/ -- In response to growing demand for compliant, accessible healthcare solutions, Qualiphy has launched a turnkey telehealth infrastructure for aesthetic clinics, medical spas, and …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 2, 2025 - 05:04 GMT

WeaponUP Now Accepts HSA/FSA Payments Through Flex

MIAMI, FL, UNITED STATES, May 2, 2025 /⁨EINPresswire.com⁩/ -- WeaponUP, the digital sword-yoga fusion platform, is proud to announce its new partnership with Flex, enabling customers to use their Health Savings Account (HSA) or Flexible Spending …

Distribution channels: Business & Economy, Gifts, Games & Hobbies ...
Published on May 2, 2025 - 04:34 GMT

Health City Robotic Surgery Transforms the Lives of Fibroid Patients

CAYMAN ISLANDS, May 1, 2025 /⁨EINPresswire.com⁩/ -- After more than a decade of living with pain and complications from uterine fibroids, a Caribbean woman has found relief through robotic-assisted surgery at Health City Cayman Islands. Ayanna, …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 2, 2025 - 12:00 GMT

ProQR Announces Webcast of Presentation at the 2025 Citizens Life Sciences Conference

LEIDEN, Netherlands & CAMBRIDGE, Mass., May 02, 2025 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer™ RNA editing technology …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on May 2, 2025 - 12:00 GMT

Vaxart to Host First Quarter 2025 Business Update and Financial Results Conference Call on May 13

Conference call to begin at 4:30 p.m. ET SOUTH SAN FRANCISCO, Calif., May 02, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NASDAQ: VXRT) today announced it will provide a business update and report financial results for the first quarter ended March 31, 2025, …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 2, 2025 - 12:00 GMT

ALX Oncology to Report First Quarter 2025 Financial Results on May 8, 2025

SOUTH SAN FRANCISCO, Calif., May 02, 2025 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (“ALX Oncology” or the “Company”) (Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on May 2, 2025 - 12:00 GMT

ARS Pharmaceuticals Announces Co-Promotion Agreement with Partner and Global Allergy Leader ALK-Abelló A/S to Expand ...

Agreement builds on landmark licensing deal between ARS Pharma and ALK-Abelló A/S, which provided ARS Pharma with $145 million upfront and ALK with commercialization rights to neffy in Canada, United Kingdom, European Union and certain other countries …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
Published on May 2, 2025 - 11:39 GMT

“Life has a way of guiding you” – Alexander’s story

Alexander reflects on his long journey with mental illness and the hope he found along the way. Dedicated to breaking the unhealthy cycles he experienced as a child, Alexander looks forward to the future with his own family. I’ve lived with long-term …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on May 2, 2025 - 11:38 GMT

Jenny's story

Jenny was diagnosed with late stage 3c ovarian cancer in 2021 at 49 years old. She experienced ovarian cancer symptoms, including fatigue, for a year preceding her diagnosis but it was linked to the perimenopause. She's an active campaigner and …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on May 2, 2025 - 11:30 GMT

Theratechnologies Presents Novel Data at ACTHIV 2025 Underscoring Importance of Managing Excess Visceral Abdominal Fat (...

VAMOS analysis highlights link between EVAF and reduced muscle quality Case series reports success with combination tesamorelin/GLP-1 receptor agonist therapy MONTREAL, May 02, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 2, 2025 - 11:30 GMT

Theratechnologies présente à la conférence ACTHIV 2025 de nouvelles données soulignant l’importance de prendre en charge ...

L’analyse réalisée dans le cadre de l’étude VAMOS met en évidence le lien entre l’excès de graisse viscérale abdominale et la diminution de la qualité musculaire Selon ce qu’on rapporte dans la série de cas, l’association de la tésamoréline à un agoniste …

Distribution channels: Healthcare & Pharmaceuticals Industry ...